Literature DB >> 18820914

[Current problems of hepatitis].

H P Dienes1, U Drebber.   

Abstract

New findings have been made in recent years on the various forms of the hepatitis virus in terms of disease course, its etiopathogenetic link with comorbidities and the definition of new forms in Central Europe. Epstein-Barr virus (EBV)- and cytomegalovirus (CMV)-induced hepatitis may occur in the so-called sero-negative group of hepatitis and direct demonstration of the viral genome in paraffin liver tissues is required to confirm the diagnosis. Since diagnosis of autoimmune hepatitis in daily practice may be difficult, a scoring system with simplified criteria has recently been developed.

Entities:  

Mesh:

Year:  2008        PMID: 18820914     DOI: 10.1007/s00292-008-1087-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

Review 1.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

Authors:  C Bréchot; V Thiers; D Kremsdorf; B Nalpas; S Pol; P Paterlini-Bréchot
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

2.  Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Yung-Ming Jeng; Wen-Ling Huang; Wei-Shiung Yang; Ming-Yang Lai; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Hepatol       Date:  2005-08       Impact factor: 25.083

3.  Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.

Authors:  K Poussin; H Dienes; H Sirma; S Urban; M Beaugrand; D Franco; P Schirmacher; C Bréchot; P Paterlini Bréchot
Journal:  Int J Cancer       Date:  1999-02-09       Impact factor: 7.396

Review 4.  Liver biopsy in hepatitis C.

Authors:  H P Dienes; U Drebber; I von Both
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

6.  Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.

Authors:  Rumi Mifuji; Yoshinao Kobayashi; Ning Ma; Qin Li Qiang; Naohito Urawa; Shinichiro Horiike; Motoh Iwasa; Masahiko Kaito; Fabio Malavasi; Yukihiko Adachi
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

7.  Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients.

Authors:  Jean-Michel Petit; Anne Minello; Valerie Jooste; Jean Baptiste Bour; Francoise Galland; Laurence Duvillard; Bruno Verges; Niels Olivier Olsson; Philippe Gambert; Patrick Hillon
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

8.  Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Masaki Takeo; Naohito Urawa; Rumi Mifuji; Hideaki Tanaka; Yoshinao Kobayashi; Motoh Iwasa; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

9.  Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

Authors:  Luca Valenti; Edoardo A Pulixi; Paolo Arosio; Laura Cremonesi; Giorgio Biasiotto; Paola Dongiovanni; Marco Maggioni; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  Haematologica       Date:  2007-07-20       Impact factor: 9.941

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.